HIV Citations List: May, 2018
1. Avirulins, a Novel Class of HIV-1 Reverse Transcriptase Inhibitors Effective in the Female Reproductive Tract Mucosa. Cherne, M.D., J. Hall, A. Kellner, C.F. Chong, A.L. Cole, and A.M. Cole. Viruses, 2019. 11(5): e408. PMID[31052477].
[PubMed]. HIV_05_2019.
2. Discovery of a Semi-synthesized Cyclolignan as a Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor. Guo, J.M., M.Y. Ba, Y. Yang, C.S. Yao, M. Yu, J.G. Shi, and Y. Guo. Journal of Asian Natural Products Research, 2019. 21(1): p. 76-85. PMID[29281889].
[PubMed]. HIV_05_2019.
3. Synthesis, Characterization, Crystal Structures and Biological Screening of 4-Amino quinazoline sulfonamide Derivatives. Kumar, A.S., J. Kudva, M. Lahtinen, A. Peuronen, R. Sadashiva, and D. Naral. Journal of Molecular Structure, 2019. 1190: p. 29-36. ISI[000467253700004].
[WOS]. HIV_05_2019.
4. New Anionic Poly(alkylideneamine) Dendrimers as Microbicide Agents against HIV-1 Infection. Maciel, D., C. Guerrero-Beltran, R. Cena-Diez, H. Tomas, M.A. Munoz-Fernandez, and J. Rodrigues. Nanoscale, 2019. 11(19): p. 9679-9690. PMID[31066407].
[PubMed]. HIV_05_2019.
5. Synthesis and Evaluation of Bifunctional Aminothiazoles as Antiretrovirals Targeting the HIV-1 Nucleocapsid Protein. Mori, M., M.C. Dasso Lang, F. Saladini, N. Palombi, L. Kovalenko, D. De Forni, B. Poddesu, L. Friggeri, A. Giannini, S. Malancona, V. Summa, M. Zazzi, Y. Mely, and M. Botta. ACS Medicinal Chemistry Letters, 2019. 10(4): p. 463-468. PMID[30996780]. PMCID[PMC6466545].
[PubMed]. HIV_05_2019.
6. Identification of 5-Substituted 2-acylaminothiazoles That Activate Tat-mediated Transcription in HIV-1 Latency Models.Nguyen, W., J. Jacobson, K.E. Jarman, H. Jousset Sabroux, L. Harty, J. McMahon, S.R. Lewin, D.F. Purcell, and B.E. Sleebs. Journal of Medicinal Chemistry, 2019. 62(10): p. 5148-5175. PMID[30973727].
[PubMed]. HIV_05_2019.
7. Pyrimidine 2,4-diones in the Design of New HIV RT Inhibitors. Romeo, R., D. Iannazzo, L. Veltri, B. Gabriele, B. Macchi, C. Frezza, F. Marino-Merlo, and S.V. Giofre. Molecules, 2019. 24(9): e1718. PMID[31052607].
[PubMed]. HIV_05_2019.
8. Synthesis and anti-HIV Profile of a Novel Tetrahydroindazolylbenzamide Derivative Obtained by Oxazolone Chemistry. Scala, A., A. Piperno, N. Micale, F. Christ, and Z. Debyser. ACS Medicinal Chemistry Letters, 2019. 10(4): p. 398-401. PMID[30996769]. PMCID[PMC6466547].
[PubMed]. HIV_05_2019.
9. Synthesis and Biological Evaluation of New HIV-1 Protease Inhibitors with Purine Bases as P2-Ligands. Zhu, M., B. Dong, G.N. Zhang, J.X. Wang, S. Cen, and Y.C. Wang. Bioorganic & Medicinal Chemistry Letters, 2019. 29(12): p. 1541-1545. PMID[31014912].
[PubMed]. HIV_05_2019.
10. Design and Characterization of Cholesterylated Peptide HIV-1/2 Fusion Inhibitors with Extremely Potent and Long-lasting Antiviral Activity. Zhu, Y., H. Chong, D. Yu, Y. Guo, Y. Zhou, and Y. He. Journal of Virology, 2019. 93(11): e02312-02318. PMID[30867304].
[PubMed]. HIV_05_2019.
Patent Citations
11. Furo[2,3-D]pyrimidine Derivatives Useful in HIV Treatment and Prevention and Their Preparation. Favre, D., R.G. Ferris, and J. Tang. Patent. 2019. 2018-IB58306 2019087016: 65pp.
[Patent]. HIV_05_2019.
12. Antiviral Pyrrolo[2,3-B]pyridine and Pyrrolo[2,3-B]pyrimidine JAK Inhibitors Useful in Treating or Preventing Retroviral and Other Viral Infections. Gavegnano, C. and R.F. Schinazi. Patent. 2019. 2018-16036670 20190134039: 82pp , Cont -in-part of U S Ser No 594,796.
[Patent]. HIV_05_2019.